treatment
Cardiovascular Concerns after HCT from the 2024 Los Angeles Patient and Family Conference
Dr. June-Wha Rhee describes the potential for cardiovascular complications after HCT, or hematopoietic stem cell transplantation, in this session from the 2024 Los Angeles Patient and Family Conference.
Living with Chronic GVHD - 2024 Los Angeles Patient and Family Conference
Dr. Karamjeet Singh explains the condition of Chronic GVHD, or Graft Versus Host Disease in this recorded session from the 2024 Los Angeles Patient and Family Conference.
Transplant for Aplastic Anemia and MDS - 2024 Los Angeles Patient and Family Conference
Dr. Ryotaro Nakamura explains the entire process for bone marrow transplantation in this recorded session from the 2024 Los Angeles Patient and Family Conference.
Advances in Treating Lower Risk MDS - 2024 Los Angeles Patient and Family Conference
Emerging Therapies in High-Risk MDS - 2024 Los Angeles Patient and Family Conference
ASH 2023 Update - Aplastic Anemia and PNH
Danicopan
VOYDEYA is a prescription medicine used along with ravulizumab or eculizumab to treat breakdown of red blood cells that takes place outside of blood vessels (extravascular hemolysis), in adults with
Recent FDA Approval of Danicopan for Patients with PNH
Dr. Caroline Piatek describes the purpose and use of this new drug approval for some patients with PNH, or Paroxysmal Nocturnal Hemoglobinuria.
Athletic Service Member Conquers Aplastic Anemia and MDS with Transplant
Damian was very active when routine blood work showed a problem. But Damian decided that going through treatment would be his mission, even if that meant two transplants. Listen here to his story.